Rupert Vessey talking at Guggenheim well worth listening to, IMO - or reviewing transcript | BMY Message Board Posts


Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  9263 of 10557  at  3/17/2022 11:39:04 AM  by

Biotech2050


 In response to msg 9254 by  Doolen
view thread

Re: Rupert Vessey talking at Guggenheim well worth listening to, IMO - or reviewing transcript

 Both presentations are a must listen to presentations. Robert’s knowledge and articulation is incredible. Sumit was also great. Last minute was best. Head to head trials: revlimid vs iberdmoide; pomalyst vs CC-92480.
 
if these trials start next year (2023) what is the earliest date we can expect meaningful data?  


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
9265 Re: Rupert Vessey talking at Guggenheim well worth listening to, IMO - or reviewing transcript JBWIN 6 3/17/2022 5:17:13 PM




Financial Market Data provided by
.
Loading...